265 related articles for article (PubMed ID: 11467477)
1. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
[TBL] [Abstract][Full Text] [Related]
2. An osteoid variant of cutaneous melanoma in a dog detected by S100 and melan a markers.
Maliver P; Estrada M; Lagadic M; Mialot M; Manin S; Fontaine JJ
J Vet Med A Physiol Pathol Clin Med; 2004 Dec; 51(9-10):413-5. PubMed ID: 15610483
[TBL] [Abstract][Full Text] [Related]
3. Use of immunocytochemical techniques in canine melanoma.
Höinghaus R; Mischke R; Hewicker-Trautwein M
J Vet Med A Physiol Pathol Clin Med; 2002 May; 49(4):198-202. PubMed ID: 12069262
[TBL] [Abstract][Full Text] [Related]
4. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
5. Metastatic melanomas in young broiler chickens (Gallus gallus domesticus).
Williams SM; Zavala G; Hafner S; Collett SR; Cheng S
Vet Pathol; 2012 Mar; 49(2):288-91. PubMed ID: 21825310
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases.
Ramos-Vara JA; Beissenherz ME; Miller MA; Johnson GC; Pace LW; Fard A; Kottler SJ
Vet Pathol; 2000 Nov; 37(6):597-608. PubMed ID: 11105949
[TBL] [Abstract][Full Text] [Related]
7. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of S100A4 in canine skin melanomas and correlation with histopathological parameters.
Grandi F; Rocha RM; Miot HA; Cogliati B; Rocha NS
Vet Q; 2014; 34(2):98-104. PubMed ID: 25023931
[TBL] [Abstract][Full Text] [Related]
9. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.
Choi C; Kusewitt DF
Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029
[TBL] [Abstract][Full Text] [Related]
12. A comparative review of melanocytic neoplasms.
Smith SH; Goldschmidt MH; McManus PM
Vet Pathol; 2002 Nov; 39(6):651-78. PubMed ID: 12450197
[TBL] [Abstract][Full Text] [Related]
13. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
14. A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter.
Kurnick JT; Ramirez-Montagut T; Boyle LA; Andrews DM; Pandolfi F; Durda PJ; Butera D; Dunn IS; Benson EM; Gobin SJ; van den Elsen PJ
J Immunol; 2001 Aug; 167(3):1204-11. PubMed ID: 11466335
[TBL] [Abstract][Full Text] [Related]
15. Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.
Berset M; Cerottini JP; Guggisberg D; Romero P; Burri F; Rimoldi D; Panizzon RG
Int J Cancer; 2001 Jan; 95(1):73-7. PubMed ID: 11241315
[TBL] [Abstract][Full Text] [Related]
16. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of melanocytic antigen PNL2, Melan A, S100, and PGP 9.5 in equine melanocytic neoplasms.
Ramos-Vara JA; Frank CB; DuSold D; Miller MA
Vet Pathol; 2014 Jan; 51(1):161-6. PubMed ID: 23370093
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining patterns of canine meningiomas and correlation with published immunophenotypes.
Barnhart KF; Wojcieszyn J; Storts RW
Vet Pathol; 2002 May; 39(3):311-21. PubMed ID: 12014495
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
[TBL] [Abstract][Full Text] [Related]
20. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
